Equities

Yatharth Hospital & Trauma Care Services Ltd

YATHARTH:NSI

Yatharth Hospital & Trauma Care Services Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)614.20
  • Today's Change4.20 / 0.69%
  • Shares traded109.91k
  • 1 Year change+51.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services, operating hospitals, and other allied services. It offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The Company provides a spectrum of specialty services in the field of Cardiology, Neurosciences, Pediatrics, Gastroenterology, Pulmonology, Gynecology, Robotic Surgery, Dermatology, Endocrinology, Dentistry, Radiology, Ophthalmology, Anesthesiology, Cancer & Bone Marrow Transplant, Nephrology & Urology, General Surgery, Psychology & Psychiatry, Orthopedics & Spine & Rheumatology, Plastic & Cosmetic Surgery, Vitro Fertilization (IVF) & Fertility, Interventional Spine & Pain Medicine. It also provides Nuclear Medicine, Pathology & Laboratory Medicine, Nutrition & Health, Physiotherapy & Rehab, Emergency Medicine, and more. It has hospitals in Noida, Jhansi, Greater Noida, Noida Extension, and Faridab.

  • Revenue in INR (TTM)7.74bn
  • Net income in INR1.29bn
  • Incorporated2008
  • Employees2.19k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
YATHARTH:NSI since
announced
Transaction
value
MGS Infotech Research & Solutions Pvt LtdAnnounced30 Oct 202430 Oct 2024Announced-6.79%10.85m
Pristine Infracon Pvt LtdDeal completed10 Feb 202410 Feb 2024Deal completed39.62%13.98m
Data delayed at least 15 minutes, as of Nov 22 2024 07:07 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GPT Healthcare Ltd4.00bn490.72m13.70bn1.89k27.585.9320.203.436.056.0549.2728.151.188.4714.012,117,117.0014.4610.1818.5012.9780.1977.9912.2810.330.952213.680.10770.0010.8518.4222.4626.15-5.19--
Shalby Ltd10.07bn547.21m23.14bn2.85k42.922.3020.402.305.035.0392.6093.850.66412.366.493,529,299.003.444.824.385.5343.5063.925.188.200.8933.560.31419.1816.0315.1024.1921.578.3919.14
Krsnaa Diagnostics Ltd6.81bn692.16m30.18bn3.70k44.713.5919.834.4320.9020.90205.92260.380.57434.923.391,841,019.005.846.727.918.5975.7582.0010.1611.741.013.890.2045--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd13.19bn1.48bn38.13bn2.98k25.807.2720.042.8916.1216.12143.8857.211.7970.8118.384,430,198.0020.0512.7427.7917.0457.5357.3211.216.732.0332.690.058833.0913.299.5743.8934.2632.3422.98
Medi Assist Healthcare Services Ltd6.81bn858.78m39.51bn3.82k46.498.0928.705.8012.0812.0295.9069.40------1,785,699.00--9.27--16.33--99.1512.7813.18--17.810.156513.7125.7018.05-8.3315.93-2.61--
Artemis Medicare Services Ltd9.09bn646.58m44.06bn1.99k73.125.5640.924.854.384.3862.1357.590.79010.00058.204,563,786.005.61--6.88------7.104.592.303.240.28634.1919.149.9627.3219.12----
Thyrocare Technologies Ltd6.23bn839.70m51.37bn1.69k61.6210.5238.558.2415.7415.74116.6892.191.054.7512.073,681,394.0013.8318.1716.0720.9770.8969.6613.2019.562.12--0.036683.578.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd7.74bn1.29bn52.40bn2.19k39.535.6230.456.7715.4415.4492.57108.590.795215.713.583,542,136.0013.2711.2714.1013.7379.4477.7616.6812.307.2086.400.08820.0028.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd20.39bn570.45m65.30bn6.15k115.627.5826.323.204.054.05145.2461.830.743520.915.923,316,034.002.23-2.263.09-3.0553.2253.783.00-3.500.84191.370.6324--12.8014.3564.08---0.3308--
Data as of Nov 22 2024. Currency figures normalised to Yatharth Hospital & Trauma Care Services Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

14.47%Per cent of shares held by top holders
HolderShares% Held
Max Life Insurance Co. Ltd.as of 30 Sep 20232.93m3.42%
Plutus Wealth Management LLPas of 30 Sep 20232.00m2.33%
Jupiter Asset Management Ltd.as of 31 Jul 20241.52m1.77%
Kotak Mahindra Life Insurance Co., Ltd.as of 30 Sep 20231.51m1.76%
ICICI Prudential Asset Management Co. Ltd.as of 31 Oct 20241.36m1.58%
Bandhan AMC Ltd.as of 31 Oct 20241.02m1.19%
Think Investments LPas of 30 Sep 20231.00m1.17%
East Capital International AB (Russia)as of 30 Sep 2024727.30k0.85%
LIC Mutual Fund Asset Management Ltd.as of 31 Oct 2024213.97k0.25%
Grandeur Peak Global Advisors LLCas of 31 Jul 2024145.66k0.17%
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.